Abaxis Inc (NASDAQ:ABAX) Sellers Increased Their Shorts By 1.81% As Of Apr 17, 2018

April 17, 2018 - By Mark Mitchell

Abaxis, Inc. (NASDAQ:ABAX) Corporate Logo

Big Money Sentiment decreased to 1.27 in Q4 2017. It has change of 0.05, from 2017Q3’s 1.32. The ratio dived due to Abaxis, Inc. positioning: 12 sold and 40 reduced. 25 funds amassed holdings and 41 increased holdings. Investors holded 21.83 million in 2017Q3 but now own 21.66 million shares or 0.81% less.
Royal Bankshares Of Canada owns 0.01% invested in Abaxis, Inc. (NASDAQ:ABAX) for 473,511 shs. Employees Retirement Association Of Colorado holds 0% in Abaxis, Inc. (NASDAQ:ABAX) or 6,537 shs. 2.22 million are owned by Primecap Mgmt Ca. Renaissance Ltd Company invested in 0.01% or 162,971 shs. Thrivent Finance For Lutherans invested in 14,129 shs. Copeland Capital Mgmt Llc owns 328,536 shs or 1.03% of their US capital. Northern Tru Corporation stated it has 0% in Abaxis, Inc. (NASDAQ:ABAX). C M Bidwell & Associates Limited accumulated 0% or 102 shs. Prudential reported 0% of its capital in Abaxis, Inc. (NASDAQ:ABAX). Piedmont Invest Advisors Limited Liability Com has 4,665 shs. Rhumbline Advisers stated it has 72,639 shs. Gemmer Asset Management Ltd Liability Company invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Spark Mgmt Limited Company holds 0.11% of its capital in Abaxis, Inc. (NASDAQ:ABAX) for 41,300 shs. Eaton Vance Management holds 0.01% or 61,220 shs. Metropolitan Life Ins Comm has 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 7,377 shs.

Abaxis, Inc. registered $2.44 million net activity with 0 insider purchases and 9 insider sales since January 30, 2018. On Tuesday, March 6 ARON KENNETH sold $98,266 worth of Abaxis, Inc. (NASDAQ:ABAX). TOCKMAN CRAIG sold $122,652 worth of Abaxis, Inc. (NASDAQ:ABAX) or 1,650 shs on Wednesday, January 31. On Tuesday, March 6 WOOD DONALD PETER had sold 10,000 shs worth $689,851. On Tuesday, February 27 the insider Henkel Achim sold $248,675. The insider EVENHUIS HENK sold 4,500 shs worth $333,460. $355,327 worth of Abaxis, Inc. (NASDAQ:ABAX) shs were sold by CASEY MICHAEL D.

Abaxis Inc (NASDAQ:ABAX) reported an increase of 1.81% in shorted shares. FINRA announced in April ABAX’s total 1.59M shorted shares. Previously was reported up change of 1.81% from 1.56M shares. 9 days will cost ABAX With 183,100 average volume to restore its previous position. Abaxis Inc’s shorted shares float is 7.32%.

Its shares touched $73.78 on during the last trading session after 2.17% change.Currently Abaxis, Inc. is uptrending after 44.47% change in last April 17, 2017. ABAX has 93,760 shares volume. The stock outperformed the S&P500 by 32.92%.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide.The firm is valued at $1.68 billion. It operates in two divisions, Medical Market and Veterinary Market.The P/E ratio is 68.31. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

Abaxis, Inc. (NASDAQ:ABAX) Ratings Coverage

In total 6 analysts cover Abaxis (NASDAQ:ABAX). “Buy” rating has 1, “Sell” are 1, while 4 are “Hold”. 17% are bullish. With $90.0 highest and $39 lowest [Target] Abaxis has $64 average [Target] or -13.26% below the current ($73.78) price. 13 are the (NASDAQ:ABAX)’s analyst reports since October 23, 2017 according to StockzIntelligence Inc. The company rating was maintained by Bank of America on Thursday, February 8. On Monday, October 30 the stock has “Hold” rating by Canaccord Genuity. On Friday, October 27 Canaccord Genuity maintained Abaxis, Inc. (NASDAQ:ABAX) rating. Canaccord Genuity has “Hold” rating and $47.0 target. The stock rating was maintained by Stifel Nicolaus with “Hold” on Monday, October 23. On Tuesday, January 9 the stock of Abaxis, Inc. (NASDAQ:ABAX) earned “Buy” rating by Northcoast. On Monday, January 29 the stock of Abaxis, Inc. (NASDAQ:ABAX) earned “Buy” rating by Northcoast. On Tuesday, January 16 the firm earned “Hold” rating by Canaccord Genuity. In Wednesday, October 25 report Bank of America maintained it with “Underperform” rating and $39 target. In Monday, January 29 report Canaccord Genuity maintained the stock with “Hold” rating. On Tuesday, January 9 Raymond James upgraded Abaxis, Inc. (NASDAQ:ABAX) to “Hold” rating.

Abaxis, Inc. (NASDAQ:ABAX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: